Columbia Dialysis is a medicare approved dialysis facility center in Columbia, Mississippi and it has 30 dialysis stations. It is located in Marion county at 1214 Highway 98 Bypass, Columbia, MS, 39429. You can reach out to the office of Columbia Dialysis at (601) 731-1234. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Columbia Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 1988. The medicare id for this facility is 252523 and it accepts patients under medicare ESRD program.
| Name | Columbia Dialysis |
|---|---|
| Location | 1214 Highway 98 Bypass, Columbia, Mississippi |
| No. of Dialysis Stations | 30 |
| Medicare ID | 252523 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 1214 Highway 98 Bypass, Columbia, Mississippi, 39429 | |
| (601) 731-1234 | |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
| NPI Number | 1952334260 |
| Organization Name | Columbia Dialysis Unit |
| Doing Business As | Hattiesburg Clinic, Pa |
| Address | 1215 Highway 98 E Columbia, Mississippi, 39429 |
| Phone Number | (601) 731-6305 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 50 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 42 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 88 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 603 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Columbia Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 88 |
| Hypercalcemia patient months | 603 |
| Patients with Serumphosphor | 93 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 3 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 82 |
| Patient months included in arterial venous fistula and catheter summaries | 577 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 8 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 1 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Columbia Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 1 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Columbia Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 282 |
| Mortality Rate in facility | 20.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 27.8 |
| Mortality Rate: Lower Confidence Limit | 14.3 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago
Columbia Dialysis Location: 1214 Highway 98 Bypass, Columbia, Mississippi, 39429 Phone: (601) 731-1234 |
News Archive
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
During a tour of the Joint Clinical Research Centre in Kampala, Uganda, on Monday, U.N. Secretary-General Ban Ki-Moon called for countries in Africa to invest 15 percent of their national budgets in HIV/AIDS programs, the Daily Monitor reports.
Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.
Cancer cases among athletes who have played on synthetic turf fields are being gathered in a ever lengthening list, reports Environment and Human Health, Inc., an organization of physicians and public health professionals.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 3 days ago